Table 1 The expression of CASC9 and its relationship with clinicopathological features of patients with OSCC

Tissue type

9.47

0.002*

   OSCC

84

53

31

   ANT

32

10

22

Age

2.647

0.266

   ≥60

38

27

11

   40–60

35

21

14

   <40

11

5

6

Gender

0.568

0.451

   Male

47

28

19

   Female

37

25

12

Tumor differentiation

2.849

0.241

   Well

28

20

8

   Moderate

31

16

15

   Poor

25

17

8

T staging

9.31

0.025*

   T1

14

5

9

   T2

21

11

10

   T3

32

23

9

   T4

17

14

3

Regional lymph node metastasis

10.063

0.002*

   No

49

24

25

   Yes

35

29

6

Clinical stage

14.227

0.003*

   I

12

4

8

   II

14

5

9

   III

38

27

11

   IV

20

17

3

Site

5.883

0.208

   Gingiva

13

10

3

   Tongue

33

24

9

   Buccal

26

14

12

   The floor of the oral

8

3

5

   Palate

4

2

2